## MPC: Marathon Petroleum Corporation - XLE: Energy

### Executive Summary

VALUE thesis: PEG 1.05 indicates fundamental undervaluation. Quality metrics strong (ROE 19%). Consistent execution (3/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($175.45)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Investors in Marathon Petroleum (NYSE:MPC) have seen massive returns of 422% over the past five years**
- Source: Simply Wall Street | 20251211T050813 | Bullish | Relevance: 100%
- Marathon Petroleum Corporation (NYSE:MPC) has delivered a massive 422% total shareholder return (TSR) over the last five years, significantly outperforming its share price return of 358%. This strong performance is attributed to the company's shift from a loss to profitability and the inclusion of dividends. Insiders have also been making significant purchases, indicating confidence in the company's future.

**2. Thrivent Financial for Lutherans Boosts Holdings in Marathon Petroleum Corporation $MPC**
- Source: MarketBeat | 20251215T120842 | Somewhat-Bullish | Relevance: 100%
- Thrivent Financial for Lutherans increased its stake in Marathon Petroleum Corporation (NYSE:MPC) by 2.9% in the second quarter, bringing its total holdings to 399,342 shares valued at approximately $66.34 million. Marathon Petroleum recently raised its quarterly dividend to $1.00 per share, representing an annualized dividend of $4.00 and a 2.2% yield, with a payout ratio of 42.6%. Despite a consensus "Hold" rating and a target price of $203.79, the company reported strong Q2 EPS of $3.01, beating estimates, and its stock currently trades around $185.63.

**3. Ghe LLC Has $4.98 Million Holdings in Marathon Petroleum Corporation $MPC**
- Source: MarketBeat | 20251215T095221 | Somewhat-Bullish | Relevance: 100%
- Ghe LLC reduced its stake in Marathon Petroleum Corporation by 22.1% to 29,974 shares, valued at approximately $4.98 million, making it their eighth-largest holding. Despite other institutional investors significantly increasing their positions, analysts maintain a "Hold" rating with an average target price near $203.79 for MPC. Marathon Petroleum also recently increased its quarterly dividend to $1.00 per share, representing a $4.00 annualized dividend and a 2.2% yield.

**4. Blue Capital Inc. Takes $2.34 Million Position in Marathon Petroleum Corporation $MPC**
- Source: MarketBeat | 20251214T080920 | Bullish | Relevance: 100%
- Blue Capital Inc. bought a new position in Marathon Petroleum Corporation (NYSE:MPC) in Q2, acquiring 14,078 shares valued at approximately $2.34 million. This investment represents 1.7% of Blue Capital's total holdings and positions Marathon Petroleum as its 19th-largest holding. Institutional investors now own 76.77% of MPC, which recently announced a boosted quarterly dividend of $1.00 and reported Q3 earnings and revenue that surpassed analyst expectations.

**5. Ilex Capital Partners UK LLP Invests $1.49 Million in Marathon Petroleum Corporation $MPC**
- Source: MarketBeat | 20251212T110832 | Neutral | Relevance: 100%
- Ilex Capital Partners UK LLP has acquired a new stake of 8,967 shares in Marathon Petroleum Corporation, valued at approximately $1.49 million, during the second quarter. This investment comes as Marathon Petroleum raised its quarterly dividend to $1.00 and reported quarterly earnings that slightly surpassed analyst estimates with $3.01 EPS and $34.81 billion in revenue. Despite analyst consensus remaining a "Hold," the company has seen increased institutional interest.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-17 | Barclays | $202 | $194 | +4% |
| 2025-11-14 | Piper Sandler | $231 | $220 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-17 | Barclays | main | Overweight |
| 2025-11-14 | Piper Sandler | main | Neutral |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 41.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 3 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.8% (-1.3%)
- Blackrock Inc.: 7.5% (-4.3%)
- State Street Corpora: 5.9% (-3.0%)
- Wellington Managemen: 3.1% (-19.8%)
- Geode Capital Manage: 2.6% (-1.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.05 suggests fair value with growth premium. Forward P/E 12.6x attractive for 40% earnings growth. Balance sheet: $1.7B free cash flow. Revenue declining -6% YoY, concerning. Institutional flow bullish (3 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $56.5B |
| Beta | 0.72 |
| 52W Range | $115.10 - $202.30 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.05 |
| Forward P/E | 12.6 |
| Current P/E | 17.6 |
| YoY Growth | 40.0% |
| EPS Direction | RISING |

### Technicals

MRS_20 stable at -3.5% (minimal 5-day change). Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). AM_20 at -3.1% indicates price below own 20MA trend. Underperforming sector by 3.5pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.10x) but short-term weakness (below SMA20). MACD histogram bearish (-0.75), momentum weakening. RSI neutral at 41. Elevated volume (1.3x 20MA), institutional activity likely. OFD pattern: -MLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.54% (CS: 13) | Weak |
| RSI_14 | 41.2 | Neutral |
| MACD Histogram | -0.75 | Bearish |
| vs SMA20 | 0.968x | Below |
| vs SMA50 | 0.972x | Below |
| vs SMA200 | 1.104x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $185.77
- **Stop Loss:** $175.45 (5.6% risk)
- **Target:** $206.41 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 96
- **Position Value:** $17,833.92
- **Portfolio %:** 17.83%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-03 (Est: $3.64)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.16 | $3.01 | -4.9% |
| 2025Q2 | $3.22 | $3.96 | +23.0% |
| 2025Q1 | $-0.54 | $-0.24 | +55.8% |
| 2024Q4 | $0.02 | $0.77 | +3730.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*